Zacks Research Lifts Earnings Estimates for Editas Medicine
Editas Medicine, Inc. (NASDAQ:EDIT – Free Report) – Zacks Research boosted their Q2 2025 earnings per share estimates for shares of Editas Medicine in a note issued to investors on Monday, June 2nd. Zacks Research analyst A. Chakraborty now anticipates that the company will post earnings of ($0.46) per share for the quarter, up from […]
Editas Medicine, Inc. (NASDAQ:EDIT – Free Report) – Zacks Research boosted their Q2 2025 earnings per share estimates for shares of Editas Medicine in a note issued to investors on Monday, June 2nd. Zacks Research analyst A. Chakraborty now anticipates that the company will post earnings of ($0.46) per share for the quarter, up from […]
